2m 2m 2m 2m 2m 2m 2m
Harmony Bioscien (HRMY)
NASDAQ
$41.67+$0.15 (+0.36%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.4BMarket Cap
- 28.19%1-Year Change
- BiotechnologyIndustry
Harmony Bioscien (HRMY)
$41.67+$0.15 (+0.36%)
HRMY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.52 | ||
Change | +$0.42 (+1.02%) | ||
Open | $41.30 | ||
High | $41.72 | ||
Low | $40.92 | ||
Previous Close | $41.10 | ||
Volume | 1,273,410 | ||
30-Day Average Volume | 759,911 | ||
1-Week Change | -1.73% | ||
1-Month Change | 5.06% | ||
1-Year Change | 28.19% | ||
3-Year Change | 9.12% | ||
5-Year Change | 14.51% | ||
Fundamentals | |||
Shares Outstanding | 58.2M | ||
Total Assets | $1.4B | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $261.3M | ||
Net Income | $75.4M | ||
Free Cash Flow | $92.4M | ||
EBIT | $96.3M | ||
EBITDA | $102.3M | ||
Net Working Capital | $580.3M | ||
EPS | $1.28 | ||
Enterprise Value/EBITDA | 20 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 2 | ||
P/E | 32 | ||
PEG | 0 | ||
Price/Free Cash Flow | 26 | ||
Price/Operating Cash Flow | 26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue